title: Integrated enrichment analysis of variants and pathways in genome-wide association studies indicates central role for IL-2 signaling genes in type 1 diabetes, and cytokine signaling genes in Crohn's disease.
abstract: Pathway analyses of genome-wide association studies aggregate information over sets of related genes, such as genes in common pathways, to identify gene sets that are enriched for variants associated with disease. We develop a model-based approach to pathway analysis, and apply this approach to data from the Wellcome Trust Case Control Consortium (WTCCC) studies. Our method offers several benefits over existing approaches. First, our method not only interrogates pathways for enrichment of disease associations, but also estimates the level of enrichment, which yields a coherent way to promote variants in enriched pathways, enhancing discovery of genes underlying disease. Second, our approach allows for multiple enriched pathways, a feature that leads to novel findings in two diseases where the major histocompatibility complex (MHC) is a major determinant of disease susceptibility. Third, by modeling disease as the combined effect of multiple markers, our method automatically accounts for linkage disequilibrium among variants. Interrogation of pathways from eight pathway databases yields strong support for enriched pathways, indicating links between Crohn's disease (CD) and cytokine-driven networks that modulate immune responses; between rheumatoid arthritis (RA) and "Measles" pathway genes involved in immune responses triggered by measles infection; and between type 1 diabetes (T1D) and IL2-mediated signaling genes. Prioritizing variants in these enriched pathways yields many additional putative disease associations compared to analyses without enrichment. For CD and RA, 7 of 8 additional non-MHC associations are corroborated by other studies, providing validation for our approach. For T1D, prioritization of IL-2 signaling genes yields strong evidence for 7 additional non-MHC candidate disease loci, as well as suggestive evidence for several more. Of the 7 strongest associations, 4 are validated by other studies, and 3 (near IL-2 signaling genes RAF1, MAPK14, and FYN) constitute novel putative T1D loci for further study.
authors.affiliation: Dept. of Human Genetics, University of Chicago, Chicago, Illinois, United States of America.
authors.forename: Peter
authors.initials: P
authors.lastname: Carbonetto
authors.forename: Matthew
authors.initials: M
authors.lastname: Stephens
mesh_terms: D001172:Arthritis, Rheumatoid / Q000235:genetics / Q000473:pathology; D016022:Case-Control Studies; D003424:Crohn Disease / Q000235:genetics* / Q000473:pathology; D003922:Diabetes Mellitus, Type 1 / Q000235:genetics* / Q000473:pathology; D003924:Diabetes Mellitus, Type 2 / Q000235:genetics / Q000473:pathology; D020022:Genetic Predisposition to Disease; D055106:Genome-Wide Association Study; D006801:Humans; D007376:Interleukin-2 / Q000235:genetics* / Q000378:metabolism; D048308:Mitogen-Activated Protein Kinase 14 / Q000235:genetics; D020641:Polymorphism, Single Nucleotide; D051076:Proto-Oncogene Proteins c-fyn / Q000235:genetics; D015398:Signal Transduction
chemical_list: D007376:Interleukin-2; C494957:FYN protein, human; D051076:Proto-Oncogene Proteins c-fyn; D048308:Mitogen-Activated Protein Kinase 14